Tolnaftate spray treatment during pregnancy

E. Czeizel, Zoltán Kazy, E. Puhó

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Teratogenic studies of tolnaftate, an antifungal agent, in humans have not been published. The population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996 contained 22,843 fetuses or newborns with congenital abnormalities and 38,151 matched controls without congenital abnormalities. The mothers of 13 cases and 13 controls were treated with tolnaftate spray during pregnancy. Four cases had congenital cardiovascular malformations in the group of cases (OR with 95% CI: 3.1, 1.0-9.7), but these cardiac defects were different. Thus, it is a signal for the potential teratogenic risk of tolnaftate in a case-control study, though the number of cases and controls were limited. Therefore, international collaboration is needed for the final conclusion.

Original languageEnglish
Pages (from-to)443-444
Number of pages2
JournalReproductive Toxicology
Volume18
Issue number3
DOIs
Publication statusPublished - May 2004

Fingerprint

Tolnaftate
Pregnancy
Antifungal Agents
Case-Control Studies
Fetus
Population
Defects

Keywords

  • Case-control study
  • Congenital cardiovascular malformations
  • Human teratogen potential
  • Tolnaftate

ASJC Scopus subject areas

  • Toxicology

Cite this

Tolnaftate spray treatment during pregnancy. / Czeizel, E.; Kazy, Zoltán; Puhó, E.

In: Reproductive Toxicology, Vol. 18, No. 3, 05.2004, p. 443-444.

Research output: Contribution to journalArticle

Czeizel, E. ; Kazy, Zoltán ; Puhó, E. / Tolnaftate spray treatment during pregnancy. In: Reproductive Toxicology. 2004 ; Vol. 18, No. 3. pp. 443-444.
@article{e78d9847ba5c449eb58d153d72de60e7,
title = "Tolnaftate spray treatment during pregnancy",
abstract = "Teratogenic studies of tolnaftate, an antifungal agent, in humans have not been published. The population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996 contained 22,843 fetuses or newborns with congenital abnormalities and 38,151 matched controls without congenital abnormalities. The mothers of 13 cases and 13 controls were treated with tolnaftate spray during pregnancy. Four cases had congenital cardiovascular malformations in the group of cases (OR with 95{\%} CI: 3.1, 1.0-9.7), but these cardiac defects were different. Thus, it is a signal for the potential teratogenic risk of tolnaftate in a case-control study, though the number of cases and controls were limited. Therefore, international collaboration is needed for the final conclusion.",
keywords = "Case-control study, Congenital cardiovascular malformations, Human teratogen potential, Tolnaftate",
author = "E. Czeizel and Zolt{\'a}n Kazy and E. Puh{\'o}",
year = "2004",
month = "5",
doi = "10.1016/j.reprotox.2004.02.008",
language = "English",
volume = "18",
pages = "443--444",
journal = "Reproductigve Toxicoloy",
issn = "0890-6238",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Tolnaftate spray treatment during pregnancy

AU - Czeizel, E.

AU - Kazy, Zoltán

AU - Puhó, E.

PY - 2004/5

Y1 - 2004/5

N2 - Teratogenic studies of tolnaftate, an antifungal agent, in humans have not been published. The population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996 contained 22,843 fetuses or newborns with congenital abnormalities and 38,151 matched controls without congenital abnormalities. The mothers of 13 cases and 13 controls were treated with tolnaftate spray during pregnancy. Four cases had congenital cardiovascular malformations in the group of cases (OR with 95% CI: 3.1, 1.0-9.7), but these cardiac defects were different. Thus, it is a signal for the potential teratogenic risk of tolnaftate in a case-control study, though the number of cases and controls were limited. Therefore, international collaboration is needed for the final conclusion.

AB - Teratogenic studies of tolnaftate, an antifungal agent, in humans have not been published. The population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996 contained 22,843 fetuses or newborns with congenital abnormalities and 38,151 matched controls without congenital abnormalities. The mothers of 13 cases and 13 controls were treated with tolnaftate spray during pregnancy. Four cases had congenital cardiovascular malformations in the group of cases (OR with 95% CI: 3.1, 1.0-9.7), but these cardiac defects were different. Thus, it is a signal for the potential teratogenic risk of tolnaftate in a case-control study, though the number of cases and controls were limited. Therefore, international collaboration is needed for the final conclusion.

KW - Case-control study

KW - Congenital cardiovascular malformations

KW - Human teratogen potential

KW - Tolnaftate

UR - http://www.scopus.com/inward/record.url?scp=1842735307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842735307&partnerID=8YFLogxK

U2 - 10.1016/j.reprotox.2004.02.008

DO - 10.1016/j.reprotox.2004.02.008

M3 - Article

C2 - 15082081

AN - SCOPUS:1842735307

VL - 18

SP - 443

EP - 444

JO - Reproductigve Toxicoloy

JF - Reproductigve Toxicoloy

SN - 0890-6238

IS - 3

ER -